Genta (company)

Genta, Inc.

Traded as	OTCQB: GNTA
Industry	Biotechnology
Headquarters	Berkeley Heights, New Jersey
Website	www.genta.com

Genta Inc. was a biopharmaceutical company based in Berkeley Heights, New Jersey, United States, which develops products for the treatment of patients with cancer. In August 2012 the company filed for bankruptcy.

Products

Its products include:

Genasense (development stage anticancer oblimersen sodium injection) ^[1]
Tesetaxel (development stage anticancer oral tubulin inhibitor)
Ganite (Genta's only U.S. Food and Drug Administration (FDA) approved drug, is a gallium nitrate injection for treatment of cancer-related hypercalcemia)

Financial record

In addition to financing agreements with institutional investors, through its history, Genta Inc., like most listed unprofitable development stage start ups, has made reverse stock splits and stock dilution in order to get financial resources and stay afloat. For example, in July 2009, the company implemented a reverse stock split, which replaced 50 old shares with one new share.^[2]

On July 9, 2008, The NASDAQ Stock Market(r) announced that it will delist the common stock of Genta Incorporated. Genta Incorporated's stock was suspended on May 6, 2008 and has not traded on NASDAQ(r) since that time. NASDAQ will file a Form 25 with the Securities and Exchange Commission to complete the delisting. The delisting becomes effective ten days after the Form 25 is filed.

Currently, Genta stock is trading on the OTC Pink Sheets

References

↑ Feuerstein, Adam (October 29, 2009). "Genta Melanoma Drug Study Disappoints: BioBuzz". TheStreet.com. Retrieved 10 January 2010.
↑ "Genta Implements Reverse Stock Split New Trading Symbol is "GETA"". Press Release. Genta Inc. July 13, 2009. Retrieved 10 January 2010.

FISHER, LAWRENCE M. (August 15, 1996). "Genta Warns That It Will End Operations if It Cannot Raise Funds". The New York Times. Retrieved 10 January 2010.
"Genta falls as drug approval delayed". The Scotsman. 4 June 2002. Retrieved 10 January 2010.
Chang, Althea (December 15, 2006). "FDA Rejects Genta Drug". TheStreet.com. Retrieved 10 January 2010.
"Anticancer drug, created at Penn, nears approval, The drug, made by Genta, could bring tens of millions a year in royalties for the school. An FDA hearing is set for Monday.". Philadelphia Inquirer. April 30, 2004. pp. C01 Business. Retrieved 10 January 2010.

External links

Official website

Pharmaceutical companies of the United States

Abbott Laboratories Acorda Therapeutics Actavis Aderis Pharmaceuticals Adolor Corporation Alcon Alexion Pharmaceuticals Alkermes Allergan Alza Amgen Amylin Pharmaceuticals ARIAD Pharmaceuticals ARYx Therapeutics Avax Technologies Baxter International BioCryst Pharmaceuticals Biogen Biolex Biovest Biovista Bradley Pharmaceuticals Bristol-Myers Squibb CancerVax Century Pharmaceuticals Cephalon Ceragenix Pharmaceuticals Combe Incorporated Cortex Pharmaceuticals CoTherix Covance Covidien Cubist Pharmaceuticals Cutter Laboratories CytoSport CytRx Danco Laboratories DNAPrint Genomics Epix Pharmaceuticals Eli Lilly and Company Elorac Endo Pharmaceuticals Ethicon Endo-Surgery Ethicon Inc. Forest Laboratories Galena Biopharma GenVec Genentech Genta Gilead Sciences Hospira ImClone Systems Institute for OneWorld Health Intercept Pharmaceuticals ISTA Pharmaceuticals Ivax Corporation Janssen Biotech Johnson & Johnson Kinetic Concepts King Pharmaceuticals Kinray KV Pharmaceutical Leiner Health Products Mallinckrodt Martek Biosciences Corporation S. E. Massengill Company McKesson Corporation McNeil Laboratories Melior Discovery Mentholatum Merck & Co. Miles Laboratories Mylan Myriad Genetics Naurex Nereus Pharmaceuticals Northwest Biotherapeutics Norwich Pharma Services NovaBay Pharmaceuticals Nuvelo Organon International Ortho Pharmaceutical Ortho-McNeil Pharmaceutical OSI Pharmaceuticals Ovation Pharmaceuticals Par Pharmaceutical Parke-Davis Perrigo Pfizer Pharmaceutical Product Development Prasco Laboratories Procter & Gamble Proteon Therapeutics Purdue Pharma Qualitest Quark Pharmaceuticals Regeneron Repros Therapeutics Rib-X Pharmaceuticals Sarepta Therapeutics Savage Laboratories Schering-Plough G. D. Searle & Company Sheffield Pharmaceuticals Smith, Kline & French Spectrum Pharmaceuticals Sterling Drug Tanox TAP Pharmaceutical Products Tec Laboratories Teva Pharmaceutical Industries Tiens Biotech Group Titan Pharmaceuticals Trevena Inc Trubion Upjohn Upsher-Smith Laboratories Valeant Pharmaceuticals Ventria Bioscience Vertex Pharmaceuticals Verus Pharmaceuticals Vion Pharmaceuticals, Inc. ViroPharma West Pharmaceutical Services Wyeth Zonite Products Corporation

List of pharmaceutical companies

Coordinates: 40°39′50″N 74°24′53″W / 40.6638°N 74.4148°W / 40.6638; -74.4148

This article is issued from Wikipedia - version of the 4/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.